arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked
Healthcare & Life Sciences, Telecoms, Media and Technology

FT Digital Health Summit 2019

Enhancing the Impact of Innovation through Collaboration

Berlin |
Speakers include:
Jens Spahn

Jens Spahn

Federal Ministry of Health, Germany

Anja Langenbucher

Anja Langenbucher

Bill & Melinda Gates Foundation

Tony  Young

Tony Young

NHS England


Hospitals and health services are under increased pressure from escalating costs and growing demand. The ability to harness digital disruption is key to easing the strain and delivering more adaptable and efficient healthcare. Collaboration and change management can facilitate implementation and help overcome the barriers posed by issues of security, engagement and integration.

Where and how can digital technologies, devices and applications, and the data they produce, have the most meaningful impact? How can they be evaluated to assess their effectiveness in terms of cost savings and enhanced experiences and outcomes for patients? To what extent can innovation promote wellness and relieve the burden on services?

The FT Digital Health Summit, now in its fifth year, will answer these questions and many more as it explores ways to implement digital transformation and improve the impact of innovation. Discussion will delve deep into the constraints and opportunities and consider how patients, hospitals, providers, innovators, investors and regulators can work together to ensure that technology is efficient and consistent in meeting the evolving needs of patients and in sustaining high-value integrated care.

fallback Add to my Calendar 06/18/2019 08:00:0006/18/2019 18:40:00trueFT Digital Health Summit 2019Hospitals and health services are under increased pressure from escalating costs and growing demand. The ability to harness digital disruption is key to easing the strain and delivering more adaptable and efficient healthcare. Collaboration and change management can facilitate implementation and help overcome the barriers posed by issues of security, engagement and integration.Where and how can digital technologies, devices and applications, and the data they produce, have the most meaningful impact? How can they be evaluated to assess their effectiveness in terms of cost savings and enhanced experiences and outcomes for patients? To what extent can innovation promote wellness and relieve the burden on services?The FT Digital Health Summit, now in its fifth year, will answer these questions and many more as it explores ways to implement digital transformation and improve the impact of innovation. Discussion will delve deep into the constraints and opportunities and consider how patients, hospitals, providers, innovators, investors and regulators can work together to ensure that technology is efficient and consistent in meeting the evolving needs of patients and in sustaining high-value integrated care.FT-Digital-Health-Summit-201913daf0b394225bfa9dc0aed02237ee98MM/DD/YYYY

Testimonials - GIF

Testimonials - Digital Health 2018 gif


2018 Photos



"Excellent investment of time. Brought the right people together to address the challenging questions“


"A great opportunity to make new connections”


“We have a huge challenge to address healthcare provision and Digital will play a key part. Great day to stimulate thinking”


"Excellent opportunity to learn and network“

Boehringer Ingelheim


Rhön-Klinikum AG press release

Speakers (19)

Jens Spahn

Jens Spahn

Federal Ministry of Health, Germany

Jens Spahn was first elected to the German Bundestag in 2002, representing the Steinfurt I/Borken I constituency. He served as health policy spokesperson of the CDU/CSU parliamentary group in the German Bundestag from 2009 to 2015 and, from 2015 to 2018, as Parliamentary State Secretary to the Federal Minister of Finance. In March 2018, he was sworn in as Federal Minister of Health.

Mr Spahn joined the Young Union (youth section of the CDU/CSU) in 1995 and the CDU in 1997. He has been chairperson of the Borken county branch of the CDU since 2005. In 2012, he became a member of the Federal Executive Committee of the CDU and was elected to the party’s Presidium at the CDU’s federal conference in Cologne in 2014.

From 2013 to 2017, he served as chairperson of the German-Netherlands Parliamentary Friendship Group. He is the editor of the book Ins Offene - Deutschland, Europa und die Flüchtlinge (Into the Open – Germany, Europe and the Refugees) that was published in 2015. Together with two physicians, he wrote the book App vom Arzt – Bessere Gesundheit durch digitale Medizin (App your health – the benefits of digital medicine), which came out in 2016.

Anja Langenbucher

Anja Langenbucher

Europe Director
Bill & Melinda Gates Foundation

Anja Langenbucher is Director of the Bill & Melinda Gates Foundation’s European Office. In this role, Anja manages the foundation’s policy, advocacy, government relations and communications activities in Europe. Based in Berlin, Anja leads a team that builds strategic relationships with various stakeholders across Europe including governments, civil society institutions, and media.

Prior to joining the foundation, Anja worked for the European Bank for Reconstruction and Development (EBRD) in a range of roles including managing the EBRD’s technical assistance program and as a transaction leader in the agribusiness team leading both debt and equity transactions. Anja also worked at the IFC/World Bank in Washington DC and for the European Commission in Brussels; she started her career at the Boston Consulting Group in Munich.

Dr Langenbucher is a German National and holds a Doctorate and Master’s Degree in Economics.

Tony  Young

Tony Young

National Clinical Lead for Innovation
NHS England

Tony Young is a practicing frontline NHS surgeon, Director of Medical Innovation at Anglia Ruskin University, and has founded 4 Med-Tech start-ups. He has also co-founded the £500m Anglia Ruskin MedTech Campus.

In 2014 he was appointed as National Clinical Director for Innovation at NHS England and in February 2016 became the first National Clinical Lead for Innovation. In this role he provides clinical leadership and support in delivering improved health outcomes in England and drives the uptake of proven innovations across the NHS, promotes economic growth through innovation and helps make the NHS the go to place on the planet for medical innovation. In 2015 he founded the NHS Clinical Entrepreneur programme. This has become the world’s largest entrepreneurial workforce development programme for clinicians and under the NHS Long Term Plan is set for a major expansion to include intrapreneurs as well as entrepreneurs.  In the 2019 New Year's Honours list Tony was awarded the OBE for services to clinical leadership.

Richard di Benedetto

Richard di Benedetto

Aetna International

Richard di Benedetto was appointed as President, Aetna International, in 2013. Following the acquisition of Aetna by CVS Health, Richard will continue in his current role, and will serve on the CVS Health Executive Management Team.

In 2014, Richard successfully led the acquisition and subsequent integration of InterGlobal, which significantly expanded Aetna’s global reach and brought valuable service expertise to the business. Richard has also been instrumental in collaborating with health care systems, government entities and plan sponsors worldwide to design locally appropriate solutions and develop new products to improve health, increase quality and drive cost effectiveness. Since 2015, the company has significantly expanded its presence in the Middle East and South East Asia, most recently with the acquisition of Bupa Thailand.

Prior to joining Aetna International, Richard spent three years as Chief Executive Officer at Euromedic International, one of the largest private equity owned European providers of diagnostic services, laboratories and cancer treatment. Richard previously spent 15 years with GE Healthcare in a number of senior leadership roles, latterly as President and Chief Executive Officer of their Eastern and Africa Growth Markets. In 2018, Richard was also appointed as a director and non-executive chairman to SleepCogni, a UK-based patented medical device with early clinical data providing a combined diagnostic and treatment system capable of identifying and helping treat sleep disorders for clinicians.

Richard holds a master’s degree in economics from the Institut d’Etudes Politiques in Paris and began his career with the Econocom Group SA based in France and Germany.

Katarina Braune

Katarina Braune

Medical Doctor and Researcher
Charité University Medical Center

As a medical doctor and researcher of the Charité, Katarina Braune's mission is to change the future of diabetes care through digital transformation. As co-chair of the NGO Hacking Health Berlin, she is actively promoting the paradigm shift in healthcare towards patient centricity, e.g. through hackathons with partners from research and industry. Living with diabetes since childhood age, she is empowering others as a global advocate, board member of scientific and patient advocacy organisations and adviser for the leading medtech companies in the diabetes sector. She started her residency as a Paediatrician during the refugee crisis at "Charité hilft", and shared her experiences in a TEDx talk:  She is currently co-leading the EU Horizon 2020-funded project “OPEN” (, investigating the “do-it-yourself” artificial pancreas, and what academia, industry and people living with diabetes can learn from each other towards the goal of making this technology available to everyone.

Megan Coder

Megan Coder

Executive Director
Digital Therapeutics Alliance

The mission of the Digital Therapeutics Alliance (DTA) is to broaden the understanding, adoption, and integration of clinically-validated digital therapeutic solutions into mainstream healthcare through education, advocacy, and research.With more than a decade of experience in the healthcare industry, Megan’s expertise extends from strategic growth and partnership development within the digital health sector, to the direct delivery of patient care. Prior to joining DTA, Megan worked with Voluntis, Iodine, the Pharmaceutical Care Management Association, and the Pharmacy Technician Certification Board.A proud Badger, Megan graduated from the University of Wisconsin—Madison School of Pharmacy and completed an Executive Residency in Association Management & Leadership with the American Pharmacists Association.

Michael Dahlweid

Michael Dahlweid

Chief Technology and Innovation Officer
Insel Group

Michael Dahlweid serves as Chief Technology and Innovation Officer at the Insel Group, the largest Swiss healthcare organization. Previously, Michael worked for global companies in executive roles, such as chief medical officer for GE Healthcare, CSC Healthcare, and AGFA. Additionally, he was running international large-scale software operations in healthcare, too. Michael received his MD, PhD in Germany, and his business education in the UK. While still seeing patients in emergency care, he also teaches healthcare information management and design thinking. His current academic focus deals with healthcare related artificial intelligence topics.

Roland Göhde

Roland Göhde

Chairman of the Board
German Healthcare Partnership (GHP)

Since 2014, Roland Göhde has been the Chairman of the Board of the German Healthcare Partnership (GHP), an initiative of the Federation of German Industries (BDI), and has been a Member of the Board of the German-African Business Association. In these honorary functions, he supports improved cooperation between associations, networks and initiatives in the healthcare sector. In addition, Roland Göhde is the main initiator of the Action Group on Ebola and the German-African Healthcare Symposium, launched in 2014. In 2017, he has been appointed as member of the World Health Summit Council. He is the Senior Managing Director of the biotechnology company Sysmex Partec GmbH. Since May 2018, he has been Chairman of the Economic Advisory Council of the German Development Agency (GIZ)

Nooman  Haque

Nooman Haque

Managing Director, Life Science & Healthcare
Silicon Valley Bank

Nooman Haque is the Managing Director of Life Sciences & Healthcare with Silicon Valley Bank’s UK Branch. He leads a team dedicated to supporting early, growth-stage and established businesses in all sectors of life sciences. He is responsible for developing new relationships, identifying lending opportunities and working with the global life sciences team to support companies with all aspects of their business. He is actively involved within the sector as a regular speaker and panellist, and also contributes to the BIA Finance sub-committee. He has also advised the UK Government and MedCity on financing issues within life sciences

Mr Haque joined Silicon Valley Bank from a venture capital firm in London and previously ran a sovereign wealth fund in Saudi Arabia largely focused on healthcare. His background includes strategic and financial advisory, debt and equity structuring and risk management.

He has a Bsc in psychology and Msc in economics, both from the University of London, and an MBA (finance) from Imperial College. He is a member of the British Psychological Society and the Royal Economic Society.

Stephan Holzinger

Stephan Holzinger

CEO and Chief Financial Officer

From 2013 to 2017, Stephan Holzinger was a member of the Supervisory Board of RHÖN-KLINIKUM AG. He held the position of Chairman of the Compliance and Communications Committee and was also a member of the Audit Committee and the Invest and Strategy Committee. Stephan Holzinger resigned from the Supervisory Board of RHÖN-KLINIKUM AG when he took over as Chief Executive and Chief Financial Officer in February 2017. At RHÖN-KLINIKUM, Stephan is responsible for Digital Transformation, Compliance, Internal Audit Communications, Investor Relations, Finance, Treasury and Controlling, as well as for business development. He also serves as the Chairman of the Supervisory Board of Germany‘s third-largest university clinic, UK Gießen-Marburg.

Additionally, he is the Chief Executive Officer of Foundation Münch, a non-profit organization which is focused on reforming the health care system.

Ilona Kickbusch

Ilona Kickbusch

Director, Global Health Centre
The Graduate Institute Geneva

Ilona Kickbusch's key interests relate to the political determinants of health, health in all policies and global health. She established the Global Health Centre at the Graduate Institute for International and Development Studies in Geneva.  She advises countries on their global health strategies and trains health specialists and diplomats in global health diplomacy. She is engaged in developing a new focus for the centre on the governance of health in the context of digital transformation.

Professor Kickbusch is a member of the Global Preparedness Monitoring Board and the WHO High-Level Independent Commission on NCDS and is co-chair of UHC 2030. She acts as Council Chair to the World Health Summit in Berlin.  She has been involved in German G7 and G20 activities relating to global health and chairs the international advisory board for the development of the German global health strategy. She initiated the @wgh300 list of women leaders in global health. She is program chair of the leaders in health network SCIANA.

Professor Kickbusch was a key instigator of the Ottawa Charter for Health Promotion and WHOs Healthy Cities Network and recently advised on the WHO activities related to Promoting Health in the SDGs.  She was the director of the Global Health Division at Yale University School of Public Health and responsible for the first major Fulbright Programme on global health. She has recently been awarded the Cross of the Order of Merit of the Federal Republic of Germany (Bundesverdienstkreuz) in recognition of her "invaluable contributions to innovation in governance for global health and global health diplomacy".

Kalle Killar

Kalle Killar

Deputy Secretary General E-services and Innovation
Ministry of Social Affairs, Estonia

Kalle Killar has over 15 years of experience working in different positions in the international organisations (European Bank for Reconstruction and Development, European Commission) and in different ministries in Estonia. Throughout his career Kalle has gathered experience in different areas from EU agriculture policy to investment banking in London that allows him to adapt to changing environment and maintain a positive attitude with an ability to find innovative solutions in the age of wicked problems.  Kalle holds a MBA in Business Administration from the University of Tartu.

Neville  Koopowitz

Neville Koopowitz


Neville Koopowitz currently serves as Chief Executive Officer of VitalityHealth, a UK private medical insurer that helps people to understand and improve their health. Vitality is the pioneer of a new approach to insurance called “shared-value insurance”, which relies on making members healthier and using the resultant insurance savings to fund incentives that motivate healthier lifestyle choices on a sustainable basis. By making people healthier, the model is one that is good for all stakeholders – members, employers, and society at large.

Prior to joining VitalityHealth, Neville played a fundamental role in the establishment of the Discovery Group, a multinational financial services organisation with operations in 14 countries, and which today covers nearly 6.5 million members worldwide. As one of its original founding employees, Neville occupied numerous Executive positions at Discovery, including the roles of Chief Marketing Officer, Head of Sales and Distribution, Managing Director of Vitality Wellness, and Chief Executive Officer of Discovery Health. Neville remains an Executive Director of Discovery.  In addition, Neville is a Board member of the Health Committee of the Association of British Insurers.

Dan Mahony

Dan Mahony

Polar Capital Partners

Dan Mahony joined Polar Capital to set up the healthcare team in 2007. They currently co-manage three global healthcare funds and a biotechnology fund with over $2 billion in AUM.  

Prior to Polar Capital, he was head of the European healthcare research team at Morgan Stanley, covering European biotechnology, medical technology and healthcare services. Previously, Dan worked in New York for ING Barings Furman Selz. Before working in the investment sector, Dan was a research scientist for seven years with the majority of his time at Schering Plough Corporation. 

Dan’s current focus is on how technology will be a catalyst for the disintermediation and disaggregation of healthcare. We are at the beginning of a major innovation cycle that will transform the way healthcare is managed, delivered and paid for.  Digital health applications and tools look set to revolutionise the way a patient is diagnosed, treated and monitored. Moreover, the rapidly emerging democratised health market will give rise to new products and services that empower consumers to maintain health and wellness. This major structural change creates risks for existing players and opportunities for newcomers and will have long-term implications for every participant in the sector.​

Manuel  Pérez Vallina

Manuel Pérez Vallina

Chief Information Officer
Hospital General Universitario Gregorio Marañón

Manuel Pérez Vallina has more than 27 years of experience as Chief Information Officer in different hospitals in Spain, including the Hospital Universitario Rio Hortega in Valladolid and Hospital Universitario La Paz in Madrid. He also served as Associate Chief Information Officer for Castilla y León Region Healthcare Authority.

He used to work as private strategy adviser in the eHealth field for different companies and non-profit organizations, as well as served in different Management Boards at National and International Level, like HL7Spain and specially SNOMED International being very active in the interoperability and terminology fields. He is member of a number of organisations including CHIME, HIMSS, SEDISA and SEIS.

During his career Manuel has published diverse articles and has been awarded with some distinctions, among them he was laureate in 2011 edition of ComputerWorld Honors Programs (Using Technology to Benefit Society) with the project “Professional Social Network for Tumour Boards”.

Manuel graduated in business administration and economics and holds a Master in information System Management and a Master in Health Administration from the Spanish National Healthcare School and the National Distance Education University.

Jaana Sinipuro

Jaana Sinipuro

Project Director
The Finnish Innovation Fund Sitra


Jaana Sinipuro is an experienced ICT professional who works as Project Director responsible for the IHAN® – Human-driven data economy focus area and also sees to the final stages of the Digital Health HUB projects. The aim of Isaacus – the Digital Health HUB is to put Finland’s poorly managed and forgotten data reserves to better use to serve the needs of research, product development and leadership. The new IHAN® project expands the opportunities of data economy to develop a sector-neutral standard for consent-based exchange of information between various operators. Jaana has more than 17 years’ experience in analytics and big data. She has background from management accounting and ICT projects. Her passion is to facilitate dialogues between business and ICT people in data driven world.

Jan-Eric Slot

Jan-Eric Slot

Council to the Board
Bernhoven Hospital

Jan-Eric Slot is the former CIO & Chief Medical Information Officer and member of the Executive Board at Bernhoven Hospital since December 2013. Currently he serves there as Council to the Board as well as Expert on Value Based Healthcare (VBHC) at the National Institute of Healthcare in the Netherlands for the National Program on Outcome Measurements for Shared Decision Making.

He was the CEO of SNOMED International from 2010-2013 and the CIO at the Academic Medical Center, Amsterdam from 2005-2010. His areas of expertise include medical informatics, medical terminology, international standards in healthcare, total quality management and general management.

Jan-Eric has more than 30 years’ experience in Healthcare IT and has held several international management positions at Shared Medical Systems, Digital Equipment Corporation, Getronics Care Services and ADAC Labs as General Manager Radiotherapy & VP EMEA. He has served on the boards of HIMSS Europe and CHIME, the College of Healthcare Information Management Executives in the US and has taught IT Governance and VBHC since 2008 at the Medical Information Science faculty at the University of Amsterdam. He also serves on the board of ZorgConnect, a regional initiative that has created and governs a Personal Health Environment for citizens in the North-East of the Dutch Province of Brabant.

Jikku Venkat

Jikku Venkat

Vice President, Product Management
Eva Weinreich-Jensen

Eva Weinreich-Jensen

HOPE - European Hospital and Healthcare Federation

With a starting point in political science, Eva Weinreich-Jensen has been working with health care issues for more than a decade, from her position in Danish Regions.

From specific strategic work with mental health, cardiology and other specific specialties in cooperation with national authorities and regions to the more overall strategic work of representing Danish Regions in Brussels at the European stage. As first vice-president and later president of HOPE, European Hospital and Healthcare Federation, Eva Weinreich-Jensen works to represent HOPE members in the European arena covering all policies with an impact on hospitals and health services. Invitations to meet the health commissioner, giving presentations and moderating workshops etc. have been important elements of her work to make progress of the mission of HOPE and its members, to promote improvements in the health of citizens and a uniformly high standard of hospital care by the European Union, fostering efficiency, effectiveness and humanity in the organization and operations of hospital and health services.


Moderator (1)

Sarah  Neville

Sarah Neville

Global Pharmaceuticals Editor
Financial Times

Sarah Neville began her career on local and regional newspapers, eventually becoming political editor of the Yorkshire Post. In 1995 she was awarded the Laurence Stern Fellowship on the Washington Post. She joined the Financial Times in 2001 and has since held a series of senior roles, including Weekend News Editor, Analysis Editor, UK News Editor and public policy editor in 2011. She was appointed Pharmaceuticals Correspondent in 2016.

Advisory Board (5)

Eugene Borukhovich

Eugene Borukhovich

Global Head of Digital Health

Eugene Borukhovich is a serial intra and entrepreneur currently serving as a Global Head of Digital Health (G4A) at Bayer. He is also an Entrepreneur in Residence at Personal Health Solutions (PHS) Capital, as well as an advisor to numerous digital health startups. Eugene enjoys mentoring startups and an avid blogger about innovation, digital health and startups. 

Denis Gilhooly

Denis Gilhooly

Chief Strategy Officer
Commonwealth Centre for Digital Health (CWCDH)

Denis Gilhooly has over thirty years of experience in the information and communications technology and global development.  He is currently Chief Strategy Officer, Commonwealth Centre for Digital Health (CWCDH), Founder & CEO, Global  He@lth 2030 Innovation Task Force and Co-Chair, Global Digital Health initiative 2030.  He has worked extensively in the public and private sectors as Executive Director, UN Digital Health Initiative, Executive Secretary, UN Broadband Commission for Digital Development, Director, ICT4D, UNDP, Executive Coordinator, UN World Summit on the Information Society, Executive Secretary, G8 Digital Opportunity Task Force, and Information Infrastructure Advise, World Bank. He was a Member of An Taoiseach’s two Advisory Committees on Telecommunications and ICT for the Government of Ireland and a Commissioner of the Global Information Infrastructure Commission.  Denis was Vice President, Business Development, Teledesic LLC (the Broadband Internet-in-the-Sky venture of Bill Gates and Craig McCaw), Media & Technology Director, The Wall Street Journal and Dow Jones & Co., and founding Editorial & Publishing Director, Communications Week International and The Networked Economy and Global Mobile Conferences. He is currently a principal within Global Partnership for Sustainable Development Data and was a member of the World Economic Forum Global Agenda Council on Digital Health.

Chris Holmes

Chris Holmes

Programme Director for Health and Medical Sciences
The Alan Turing Institute

Chris Holmes is Programme Director for Health and Medical Sciences at The Alan Turing Institute. His appointment is made jointly with Health Data Research UK.  He is Professor of Biostatistics at the University of Oxford with a joint appointment between the Department of Statistics and the Nuffield Department of Clinical Medicine through the Wellcome Trust Centre for Human Genetics and the Li Ka Shing Centre for Health Innovation and Discovery

Before joining Oxford, Chris was based at Imperial College, London, and also worked in industry conducting research in scientific computing. He holds a Programme Leader’s award in Statistical Genomics from the Medical Research Council UK. In 2016, WIRED UK magazine named him one of the ‘Innovators of the year in AI’.

Chris has a broad interest in the theory, methods and applications of statistics and statistical modelling. He is particularly interested in pattern recognition and nonlinear, nonparametric statistical machine learning methods applied to the genomic sciences and genetic epidemiology.

Niklas Kramer

Niklas Kramer

Senior Policy Advisor
Federal Ministry of Health, Germany

Niklas Kramer has worked since 2016 as Senior Policy Advisor in the Federal Ministry of Health in the Directorate on Digitalisation and Innovation. Before he held positions at a German social policy forum and in the office of a Member of the German Federal Parliament. Mr Kramer studied Public Policy and European Studies with a focus on Social and European Policy in Erfurt and Frankfurt Oder, spending exchange semesters in Colchester (UK) and Wroclaw (Poland).

Chris  Sawyer

Chris Sawyer

Innovation Lead for Digital Health
Innovate UK

Chris Sawyer leads on digital health at Innovate UK and has over 30 years’ experience in the healthcare technology sector.  Chris has been instrumental in the development and management of market leading medtech solutions at the cutting edge of the medical technologies sector. Having worked for global market leading medical technology companies, Chris also went on to complement this work through his work with the NHS when supporting the development of new innovative technological solutions for NHS Innovation Hubs.

Innovate UK in part of UK Research and Innovation and is the UK's innovation agency. It funds, supports and connects innovative British businesses through a unique mix of people and programmes to accelerate sustainable economic growth


Agenda - 18th Jun

  • 8:00am
    Registration and networking
  • 8:50am
    Opening remarks from the chair

    Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 9:00am
    Opening address: Realising a shared vision for health

    Jens Spahn, Minister, Federal Ministry of Health

  • 9:30am
    Health leaders' panel: Collaboration as a catalyst for transformation

    Healthcare systems around the world are pursuing transformation in their quest to improve quality, access and affordability. The investor mix is changing as the digital health landscape evolves and matures and new players and partnerships emerge. Patients, insurers, innovators, regulators and investors are working collaboratively with healthcare providers to facilitate a smooth transition but how can diverse strategies be aligned to ensure meaningful impact and outcomes?

    • How are relationships and partnerships helping to navigate technological and cultural change toward digitalisation? What constraints are limiting the transition?
    • How are tech giants and start-ups forming alliances with providers and moving into the healthcare space?
    • What new skills and leadership models are needed to spearhead the transformation?
    • What can we learn from experiences of delivering digital interventions at scale?

    Stephan Holzinger, CEO and Chief Financial Officer, Rhön-Klinikum

    Kalle Killar, Deputy Secretary General E-services and Innovation, Ministry of Social Affairs, Estonia

  • 10:20am
    Keynote interview

    Tony Young, National Clinical Lead for Innovation, NHS England

  • 10:40am
    Networking break
  • 11:00am
    Hospital 4.0 discussion: Investing for the future

    From automated registration and diagnostic imaging to patient monitoring and robot-assisted surgery no area of the hospital will remain untouched by the wave of digital change. Unlocking the benefits of disruption is beset by challenges, not least those posed by issues of security, engagement and integration. This panel will explore how to avoid the pitfalls and achieve enhanced operational efficiency and quality of care.

    • What will the hospital of the future look like? How are digital technologies being integrated into ageing hospitals or being built into new facilities?
    • What do tech-enabled solutions offer in terms of value and secure investment?
    • How is AI changing the way healthcare is delivered?
    • Can the potential of a virtual hospital be realised?
    • How can robust and reliable infrastructure support operational efficiencies in the digital age?

    Michael Dahlweid, Chief Technology and Innovation Officer, Insel Group

    Manuel Pérez Vallina, Chief Information Officer, Hospital General Universitario Gregorio Marañón

    Eva Weinreich-Jensen, President, HOPEEuropean Hospital and Healthcare Federation

  • 11:50am
    Fireside chat: Innovation’s route to market

    Technology developers face a challenging journey to bring their products to market. As well as engaging with multiple stakeholders they need to demonstrate safety and performance and steer through complex regulatory processes. Here we will shine a light on best practices for upscaling business and closing the gap between product development and adoption.

  • 12:10pm
    Spotlight session: The patient’s digital pathway: now it’s personal

    How can digital touchpoints be tailored to the individual when there are so many different needs and preferences? This discussion will focus on ways of connecting and personalising the patient’s journey to deliver new and better end-user experiences and customised health interventions.

    • What do patients want and how do they define value? To what extent can and should the patient be in control of their own information?
    • What is the reality of digital health when it comes to providing a seamless care experience?
    • Do we risk creating a chasm between the tech-savvy and ‘no smartphone’ individuals? How do different patient groups intersect with technology and how can acceptance and engagement be improved?
    • How is the focus on the patient influencing decision-making? What is being done to integrate the patient voice into the development phase of new technologies and services?

    Richard di Benedetto, President, Aetna International

    Katarina Braune, Medical Doctor and Researcher, Charité University Medical Center

    Dan Mahony, Partner, Polar Capital Partners

  • 12:50pm
  • 1:50pm
    Keynote address: Moving pharma into the digital era
  • 2:10pm
    Discussion panel: Digiceuticals – threat or opportunity?

    Here we will consider the realities and opportunities of digiceuticals and the extent to which they can take pharma beyond the pill. The discussion will explore how software interventions and pharma collaboration are helping to advance treatment and manage disease.

    • What role can digital therapeutics play in managing patient interactions and in future treatment models?
    • Meeting the need for regulatory approval and clinical validation: How do you establish criteria to demonstrate safety and effectiveness?
    • What new investment opportunities are emerging? What are the collaboration benefits for pharma and digital innovators?

    Megan Coder, Executive Director, Digital Therapeutics Alliance

  • 2:50pm
    Global conversation: closing the health divide

    In 2018 delegates at the WHO World Health Assembly agreed a resolution to prioritise the greater use of digital technologies to improve access to healthcare for those most in need around the world. This conversation will assess global progress in digital health adoption and in expanding the scope of services.

    • How can we extend the reach of digital health and move the global health agenda forward?
    • How do you decide which approaches will have the most significant impact and how can progress be monitored?
    • Can countries without incumbent systems leapfrog development and embrace digital health more swiftly than those with legacy services? What are the advantages of starting from the ground up?

    Roland Göhde, Chairman of the Board, German Healthcare Partnership (GHP)

    Anja Langenbucher, Europe Director, Bill & Melinda Gates Foundation

  • 3:30pm
    Networking break
  • 3:50pm
    Keynote presentation
  • 4:10pm
    Cross-sector discussion: Enhancing the value and impact of data

    Data volumes are growing exponentially and there is an increasing drive to extract value and enhance the impact of data. Making sense and use of the huge amount of information being generated is all the more challenging as much of it exists in silos across the health spectrum. This session will home in on ways of creating and maintaining secure systems to support the capture, management, analysis and sharing of data.

    • What does value mean when it comes to data? How can the flow of information and extraction of insights be improved whilst resolving issues of ownership, standards, privacy and security?
    • In what ways are AI analytics and IoT connectivity facilitating insight generation and data sharing?
    • How can social media and non-medical data sources be leveraged? How are concerns about the ethical use of personal data being addressed?

    Nooman Haque, Managing Director, Life Science and Healthcare, Silicon Valley Bank

    Jaana Sinipuro, Project Director, The Finnish Innovation Fund Sitra

    Jan-Eric Slot, Council to the Board, Bernhoven Hospital

  • 4:50pm
    Discussion panel: Promoting wellness - prevention as the best cure for healthcare

    Prevention is growing ever more critical as healthcare systems grapple with escalating costs and rising demand for their services. Efforts are focused on public health and empowering individuals to take more proactive control of their wellness, and so reduce the burden on services.

    • How can the benefits of digital preventative solutions be assessed and can they make a long-term difference?
    • How do you improve the impact of prevention on healthcare costs?
    • What can boost adoption and adherence rates for wellbeing management tools?

    Ilona Kickbusch, Director, Global Health Centre, The Graduate Institute Geneva

    Neville Koopowitz, CEO, VitalityHealth

  • 5:30pm
    Concluding remarks
  • 5:40pm
    Drinks reception

Why Attend

  • Assess how patients are being empowered and further involved in the transformation of healthcare
  • Hear how collaborations between pharma and big tech are enriching the commercial viability of digital health
  • Meet and greet with the full array of industry stakeholders, from healthcare to technology, pharma to start-ups, regulation to government
  • Identify solutions in overcoming cyber security threats in digital health
  • Don’t get left behind - be part of a must-attend event mapping the continued transformation of healthcare

Who attends

FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years. 

The FT Digital Health Summit Europe will be attended by: 

- Pharmaceutical and biotechnology companies 
- Healthcare Providers
- Medical Device manufacturers 
- Health insurers
- Investment banks 
- Hospital Management
- Clinicians




Ticket Type


Early Bird Ticket (Ends on 28 February)


Standard Ticket




The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of 985,000, three-quarters of which are digital subscriptions. It is part of Nikkei Inc, which provides a broad range of information, news and services for the global business community. 



The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.


Maritim proArte Hotel
Friedrichstraße 151
10117 Berlin


Tel: +49 (0) 30 2033-5



  • Gain access to 150 Senior Executives from the Digital Health Industry, who will be attending the event;
  • Brand alignment with the FT and its unrivalled credibility;
  • Demonstrate thought leadership around the current critical issues affecting the healthcare industry;
  • Benefit from sustained international visibility through our advertising and marketing campaigns

Joe Hames

Commercial Manager, Global Industries

T: +44 (0)207 873 4551

M: +44 (0)791 329 2038



Contact Us

Alexsandra Silva
Media Partner and Press Enquiries
Financial Times
Joe Hames
Sponsorship Opportunities
Financial Times
Ailsa Matkevich
Speaking Opportunities
Financial Times
FT Live Delegate Services - EMEA
Delegate Booking and Registration Enquiries
Financial Times